ABT Abbott Laboratories

bearish · high conviction track record → $85.60 -0.70 (-0.8%)
Mkt Cap $151B P/E 24.3 fwd 14.3 52wk $81.97 - $139.06 5d ago
Factor divergence: DIVERGENCE: insider_activity bullish vs price_momentum, analyst_revisions bearish
Est. revisions: -0.1%
Factor Model (net -1.4)

Factor Model

net -1.4 4.7 / 10
Est. Revisions
-0.0
Insider Activity
+0.5
Momentum
-0.5
Analyst Rev.
-1.0
Narrative Gap
+0.0

Abbott Slides on Nutrition Headwinds

Watch: Upcoming Q1 earnings for guidance on nutrition recovery and overall growth.

Abbott Laboratories shares dropped after missing estimates due to nutrition headwinds. Stock closed at $87.77, down 5.81% last month and 33.43% annually. Revenue growth decelerated to 7.8%, EPS estimates revised down 3.4%, with insider selling alongside some insider buying clusters present.

Failed guidance and nutritional business pressure intensify investor worries about Abbott's growth and profits outlook.

Evidence

5d ago Abbott Laboratories (ABT) Slid on Headwinds in Nutrition Business yahoo-finance
17d ago Jim Cramer Compares the Current Selloff in Abbott Labs to the 1999 Market Environment yahoo-finance
18d ago Abbott stock? reddit-stocks
20d ago ABOTT(ABT) opinions reddit-stocks
24d ago Let’s talk about Abbot Labs (ABT) reddit-stocks
32d ago Insider buy by STARKS DANIEL J (ABT): $926,537
33d ago Insider buy by BOUDREAU PHILIP P (ABT): $201,300
34d ago BTIG reit ABT: Buy → Buy
7 older signals
36d ago Daiwa Downgrades Abbott Laboratories (ABT), Sees Limited Upside
41d ago Abbott: A Hidden Gem
41d ago Barclays main ABT: Overweight → Overweight
44d ago B of A Securities main ABT: Buy → Buy
44d ago Evercore ISI Group main ABT: Outperform → Outperform
44d ago Benchmark main ABT: Buy → Buy
44d ago RBC Capital main ABT: Outperform → Outperform
Fundamentals & Data ▾
Abbott Laboratories Healthcare · Medical Devices
Mkt Cap
$151B
P/E
24.3 fwd 14.3
Beta
0.65
Div Yield
291.00%
52w Range
$81.97 - $139.06
Short Interest
22.5M 1.45%
Days to Cover
1.8 -5%
Technicals downtrend
vs 20d MA
-0.8%
from 52w Hi
-16.8%
Vol (20d)
25%
1w return
-2.5%
1m return
-6.3%
Vol ratio
1.0x
Insiders
selling 2B / 5S
Analysts
mixed
EPS Estimate
$1.28 -0.1% 30d 0up / 6dn
Est. Dispersion
2% 23 analysts
Analyst Target
$118 $92 - $143
Options P/C
0.38
Financials
Revenue
$11.2B +8% YoY
FCF
$916M
Gross Margin
56%
Op Margin
12%
Momentum: decelerating
Top Holders
Renaissance $127M
Track Record (0/1 correct) ▾

Direction History

0/1 correct at 5 days
2026-05-07 bullish -2.4% ✗
Full track record across all stocks →
15 signals · latest 5d ago

Keep reading the market

Direction shifts, insider clusters, filing red flags, and earnings call changes stay published on the site.

All stocks → Track record → How it works →